-
Signature
-
Marta Woods by Power of Attorney
-
Stock symbol
-
LRCX
-
Transactions as of
-
Feb 20, 2025
-
Transactions value $
-
-$9,907,200
-
Form type
-
4
-
Date filed
-
2/21/2025, 01:28 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
LRCX |
Common Stock |
Options Exercise |
$680K |
+35.8K |
+19.97% |
$19.01 |
215K |
Feb 20, 2025 |
Direct |
F1, F2 |
transaction |
LRCX |
Common Stock |
Sale |
-$3.22M |
-35.8K |
-16.64% |
$90.00 |
179K |
Feb 20, 2025 |
Direct |
F1, F2 |
transaction |
LRCX |
Common Stock |
Options Exercise |
$1.31M |
+74.3K |
+41.5% |
$17.68 |
253K |
Feb 20, 2025 |
Direct |
F1, F2 |
transaction |
LRCX |
Common Stock |
Sale |
-$6.69M |
-74.3K |
-29.33% |
$90.00 |
179K |
Feb 20, 2025 |
Direct |
F1, F2 |
holding |
LRCX |
Common Stock |
|
|
|
|
|
2.37K |
Feb 20, 2025 |
By 401(k) |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
LRCX |
Employee Stock Option (Right to Buy) |
Options Exercise |
-$680K |
-35.8K |
-100% |
$19.01 |
0 |
Feb 20, 2025 |
Common Stock |
35.8K |
$19.01 |
Direct |
F1, F3 |
transaction |
LRCX |
Employee Stock Option (Right to Buy) |
Options Exercise |
-$1.31M |
-74.3K |
-100% |
$17.68 |
0 |
Feb 20, 2025 |
Common Stock |
74.3K |
$17.68 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: